Graham Capital Management, L.P. Abbott Laboratories Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Graham Capital Management, L.P. holds 5,863 shares of ABT stock, worth $673,541. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,863Holding current value
$673,541% of portfolio
0.02%Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,134Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.55 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.25 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.58 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $201B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...